Deep Sequencing of 3 Cancer Cell Lines on 2 Sequencing Platforms
Demographics (2)
- AGE - Subject age at enrollment (phv00417364.v1.p1)
- SEX - Self-reported sex (phv00417362.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case status of the subject for (phv00417361.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00417363.v1.p1)
Other (15)
- ANALYTE_TYPE - Analyte type (phv00417367.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00417366.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00417355.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00417369.v1.p1)
- IS_TUMOR - Tumor status (phv00417368.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00417370.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00417371.v1.p1)
- SAMPLE_ID - Sample ID (phv00417365.v1.p1)
- SAMPLE_ID - Sample ID (phv00417359.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00417372.v1.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00417357.v1.p1)
- SUBJECT_ID - Subject ID (phv00417360.v1.p1)
- SUBJECT_ID - Subject ID (phv00417354.v1.p1)
- SUBJECT_ID - Subject ID (phv00417358.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00417356.v1.p1)